Rosenberg Matthew Hamilton

Source: SEC Form 13F · as of Mar 2026

Rosenberg Matthew Hamilton holds 34 biotech & pharma companies tracked by BioSniper, totaling $6.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

34

Total value held

$6.8M

CompanySharesValue
JNJJOHNSON & JOHNSON3,811$932K
ABBVAbbVie Inc.3,994$869K
MRKMerck & Co., Inc.5,130$617K
LLYELI LILLY & Co650$598K
AMGNAMGEN INC1,316$463K
PMPhilip Morris International Inc2,355$389K
CAHCardinal Health Inc.1,802$381K
UNHUnitedHealth Group Incorporated Common Stock (DE)1,370$371K
GILDGILEAD SCIENCES, INC.2,505$349K
ABTABBOTT LABORATORIES2,941$302K
GMOptec International, Inc.3,467$258K
MCKMcKesson Corporation248$215K
NVSNovartis AG1,342$205K
TEVATeva Pharmaceutical Industries Limited6,108$184K
NVONovo Nordisk A/S3,843$141K
SNYSanofi2,380$115K
VRTXVERTEX PHARMACEUTICALS INC / MA184$82K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)1,376$76K
REGNREGENERON PHARMACEUTICALS, INC.60$46K
BMYBRISTOL MYERS SQUIBB CO696$42K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)1,723$32K
ZTSZoetis Inc.264$31K
PFEPFIZER INC866$24K
GEHCGE HealthCare Technologies Inc.324$23K
DGXQuest Diagnostics Incorporated110$22K
CORCencora Inc.44$14K
SUNSUNSET ISLAND GROUP188$12K
DVADaVita Inc.68$10K
SMMTSummit Therapeutics Inc.501$9K
BIIBBIOGEN INC.35$6K
ELANElanco Animal Health Inc139$3K
ARGXARGENX SE3$2K
PBIPROVENTION BIO, INC.100$1K
ALNYALNYLAM PHARMACEUTICALS, INC.3$993

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Rosenberg Matthew Hamilton — Biotech 13F Holdings & Portfolio | BioSniper